Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
2055013-55-1
1807534-84-4
1309460-27-2
1310680-33-1
1415408-70-6
92417-25-9 | Thp-peg12 | AA019ECG | MFCD31380395
2183473-37-0 | BDP TR maleimide | AA019EGB | MFCD31580099
1571034-51-9 | 1-(4-(Trifluoromethoxy)Phenyl)Ethanone O-(4-Methoxybenzyl) Oxime | AA019EJB | MFCD30472081
367966-67-4 | (2S,4S)-1-tert-Butyl 2-methyl 4-((tert-butyldimethylsilyl)oxy)-5-oxopyrrolidine-1,2-dicarboxylate | AA019EMI | MFCD29917030
428470-14-8 | N-(4-chloro-3-(trifluoromethyl)phenyl)-4-methylbenzenesulfonamide | AA019EPO | MFCD01348409
54839-12-2 | 1-(4-Chlorophenyl)-2-cyclopropylethanone | AA019ET1 | MFCD16665463
1427424-50-7 | 7-chloroimidazo[1,5-a]pyridine | AA019EWC | MFCD23711121
496955-47-6 | N,N-Dibenzyl-2-chloro-9h-purin-6-amine | AA019EZG | MFCD31555266
103476-24-0 | D-Myo-Inositol-1,4,5-trisphosphate tripotassium salt | AA019FSV | MFCD00077799
438029-90-4 | 4-({[3-(trifluoromethyl)phenyl]carbamoyl}methoxy)benzoic acid | AA019GE3 | MFCD03478323